Literature DB >> 3216969

Combined treatment of osteosarcoma of the spine.

N Sundaresan1, G Rosen, A G Huvos, G Krol.   

Abstract

We reviewed the clinical features and results of treatment in 24 patients with osteogenic sarcoma of the spine treated over a 35-year period. There were 14 male and 10 female patients 13 to 71 years old. The tumor arose de novo in 13 patients and was secondary to other conditions in 11. All patients presented with pain, and 16 (67%) had neurological deficits. Patients were divided into two treatment groups. Thirteen patients treated from 1949 to 1977 usually underwent limited tumor resection and external radiation therapy. The second group, 11 patients treated from 1978 to 1984, underwent more aggressive surgical resection and received combination chemotherapy as well as local radiation to the tumor bed. In the second group, there were 5 long term survivors, and only 1 patient developed metastatic disease while on therapy. Failure to obtain local control was the major cause of treatment failure. Complete surgical resection of the tumor by spondylectomy and combination chemotherapy offer the best prospect for cure of osteogenic sarcoma of the spine.

Entities:  

Mesh:

Year:  1988        PMID: 3216969     DOI: 10.1227/00006123-198812000-00005

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  17 in total

1.  Case report 741: Chondromyxoid fibroma of T2.

Authors:  H Tsuchiya; K Tomita; T Tsuchida; Y Ueda; A Roessner; M Suzuki
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

2.  Modified total en bloc spondylectomy in thoracic vertebra tumour.

Authors:  Changan Guo; Zuoqin Yan; Jian Zhang; Chun Jiang; Jian Dong; Xiaoxing Jiang; Qinming Fei; Dehua Meng; Zhengrong Chen
Journal:  Eur Spine J       Date:  2010-11-13       Impact factor: 3.134

3.  Primary malignant bone tumors and solitary metastases of the thoracolumbar spine: results by management with total en bloc spondylectomy.

Authors:  Ingo Melcher; Alexander C Disch; Cyrus Khodadadyan-Klostermann; Stefan Tohtz; Mirko Smolny; Ulrich Stöckle; Norbert P Haas; Klaus-Dieter Schaser
Journal:  Eur Spine J       Date:  2007-01-25       Impact factor: 3.134

4.  Surgical management of recurrent thoracolumbar spinal sarcoma with 4-level total en bloc spondylectomy: description of technique and report of two cases.

Authors:  Claudia Druschel; A C Disch; I Melcher; T Engelhardt; A Luzzati; N P Haas; K D Schaser
Journal:  Eur Spine J       Date:  2011-08-05       Impact factor: 3.134

Review 5.  Clinical effectiveness of Enneking appropriate versus Enneking inappropriate procedure in patients with primary osteosarcoma of the spine: a systematic review with meta-analysis.

Authors:  Bruno Pombo; Ana Cristina Ferreira; Pedro Cardoso; António Oliveira
Journal:  Eur Spine J       Date:  2019-08-13       Impact factor: 3.134

6.  The results of surgery on primary malignant tumors of the spine.

Authors:  H Takaishi; H Yabe; Y Fujimura; N Suzuki; Y Toyama
Journal:  Arch Orthop Trauma Surg       Date:  1996       Impact factor: 3.067

7.  Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.

Authors:  Armin Arshi; Justin Sharim; Don Y Park; Howard Y Park; Hamed Yazdanshenas; Nicholas M Bernthal; Arya N Shamie
Journal:  Spine J       Date:  2016-11-14       Impact factor: 4.166

8.  Primary spinal column sarcomas.

Authors:  E Tasdemiroglu; E Bagatur; I Ayan; E Darendeliler; R A Patchell
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

9.  Total en bloc spondylectomy for spinal tumors: improvement of the technique and its associated basic background.

Authors:  Katsuro Tomita; Norio Kawahara; Hideki Murakami; Satoru Demura
Journal:  J Orthop Sci       Date:  2006-01       Impact factor: 1.601

10.  Association of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database.

Authors:  Debraj Mukherjee; Kaisorn L Chaichana; Scott L Parker; Ziya L Gokaslan; Matthew J McGirt
Journal:  Eur Spine J       Date:  2012-12-21       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.